Skip to main content
Premium Trial:

Request an Annual Quote

MDL to Distribute Inpharmatica s Biopendium Database

NEW YORK, Feb. 24 (GenomeWeb News) - MDL Information Systems and Inpharmatica today said that MDL would serve as a non-exclusive distributor for Inpharmatica's Biopendium proteome annotation database.

Under the agreement, MDL, a wholly owned subsidiary of scientific publisher Elsevier with sales offices in 11 countries, will offer both installed and hosted versions of Biopendium worldwide, excluding Japan. Other terms of the agreement were not disclosed.

Inpharmatica said that the distribution agreement would allow it to devote more resources to building its drug discovery business.

Current subscribers to Biopendium include Pfizer, Aventis, Daiichi, Genentech, Serono, Riken, and UCB Pharma.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.